Company profile
Pharmaceutical Manufacturing

Cadila Pharmaceuticals Limited - Company Intelligence Profile

Industry: Pharmaceutical Manufacturing | Founded: 1951 | HQ: Ahmedabad, India

Founded by Shri I.A. Modi, Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last seven decades, the company has been developing and manufacturing pharmaceutical products in India and selling and...

Datakart tracks firmographic, hiring, traffic, technology, funding, review, and leadership signals for Cadila Pharmaceuticals Limited to help teams evaluate the account with useful business context.

Cadila Pharmaceuticals Limited logo

Privately Held

Cadila Pharmaceuticals Limited

cadilapharma.com

Employees

9.3K

Monthly visits

20.4K

Open roles

9

Search volume

27.1K

Company Snapshot

Founded by Shri I.A. Modi, Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last seven decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over hundred other countries around the world.

Focused strongly on Innovation and Research, the company is present in more than forty-five therapeutic areas spread across twelve specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals.

At Cadila Pharmaceuticals, Research and Development is at the core of all its initiatives, be it Biotechnology, APIs, Formulations, Plant Tissue Culture or Phytochemistry.

More than 300 scientists in its various Research and Development setups reinforce the competitiveness of research in the therapeutic areas which have high unmet medical needs.

Cadila Pharmaceuticals Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company’s formulations manufacturing plant at Dholka near Ahmedabad, Gujarat is spread over hundred acres of land. This state-of-the- art facility is not only impressive in size, but is also USFDA approved.

The second formulations manufacturing facility is located at Samba in Jammu and Kashmir. The facility meets most of the stringent quality standards across the globe to produce tablets, capsules, soft and hard gelatin capsules, liquids and orals.

Two Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture a wide range of APIs and intermediates including many USFDA-certified products.

The company has strong foothold in the African continent through its formulation manufacturing facility at Addis Ababa in Ethiopia.

For more information visit: https://www.cadilapharma.com/

1951

Founded

9.3K

Employee count

20.4K

Monthly website visits

9

Open roles

Company Snapshot Details

Legal name: Cadila Pharmaceuticals Ltd.
Headquarters: Ahmedabad, Gujarat, India
Industry: Pharmaceutical Manufacturing
Sub-sector: Pharmaceutical Manufacturing
Website: https://www.cadilapharma.com
YoY headcount growth: not publicly disclosed
Company stage: Privately Held
Last updated: Thu, 23 Apr 2026
Company intelligence

Business signals that help qualify Cadila Pharmaceuticals Limited

This profile combines firmographic, traffic, hiring, employee, review, compensation, technology, funding, leadership, and product availability signals so visitors can answer practical business questions without hunting across multiple data sources.

Source snapshot

Last refreshed 2026-04-23 | 27K search volume | Domain cadilapharma.com

Annual revenue
$2.5B
Reported annual revenue from the source dataset when available.
Acquisitions captured
1
Number of acquisition records captured across the available source columns.
Monthly visits
20.4K
Latest monthly visits value available from the source dataset.
Global web rank
#794,135
Lower rank values indicate stronger web visibility in the source dataset.
Employees
9.3K
Latest employees value available from the source dataset.
Employee reviews
396
Latest employee reviews value available from the source dataset.
+1 monthly (+12.5%)
Hiring demand
9
Open roles reveal which teams may be expanding and where vendor demand can emerge. For Cadila Pharmaceuticals Limited, this signal is based on the latest available source snapshot.
+126 monthly (+1.4%)
Headcount momentum
9.3K
Recent employee count movement helps qualify growth, contraction, and operational scale. For Cadila Pharmaceuticals Limited, this signal is based on the latest available source snapshot.
+8.2K monthly (+1.4%)
Audience growth
602.7K
LinkedIn follower movement is a useful proxy for employer brand, market attention, and hiring reach. For Cadila Pharmaceuticals Limited, this signal is based on the latest available source snapshot.
+1.9K monthly (+10.4%)
Web demand
20.4K
Website traffic movement helps benchmark customer interest and go-to-market momentum. For Cadila Pharmaceuticals Limited, this signal is based on the latest available source snapshot.
+1 quarterly
Employee sentiment
4.0
Employee review movement can surface internal confidence, culture stability, and retention risk. For Cadila Pharmaceuticals Limited, this signal is based on the latest available source snapshot.
Identity atlas

Cadila Pharmaceuticals Limited identity, aliases, ownership, and taxonomy

This section makes the entity easier to verify: canonical domains, alternate names, descriptions, ownership flags, parent or acquirer context, industry codes, and source-level social reach are grouped together.

Company descriptions
All available company description fields from the source dataset.
Company descriptiondescription

Founded by Shri I.A. Modi, Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last seven decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over hundred other countries around the world. Focused strongly on Innovation and Research, the company is present in more than forty-five therapeutic areas spread across twelve specialities, including cardiovascular, gastrointestinal, analgesics, haematinics, anti-infectives and antibiotics, respiratory agents, antidiabetics and immunologicals. At Cadila Pharmaceuticals, Research and Development is at the core of all its initiatives, be it Biotechnology, APIs, Formulations, Plant Tissue Culture or Phytochemistry. More than 300 scientists in its various Research and Development setups reinforce the competitiveness of research in the therapeutic areas which have high unmet medical needs. Cadila Pharmaceuticals Excellence in manufacturing facilities is central to Cadila Pharmaceuticals. The company’s formulations manufacturing plant at Dholka near Ahmedabad, Gujarat is spread over hundred acres of land. This state-of-the- art facility is not only impressive in size, but is also USFDA approved. The second formulations manufacturing facility is located at Samba in Jammu and Kashmir. The facility meets most of the stringent quality standards across the globe to produce tablets, capsules, soft and hard gelatin capsules, liquids and orals. Two Active Pharmaceutical Ingredient (API) manufacturing units at Ankleshwar, Gujarat manufacture a wide range of APIs and intermediates including many USFDA-certified products. The company has strong foothold in the African continent through its formulation manufacturing facility at Addis Ababa in Ethiopia. For more information visit: https://www.cadilapharma.com/

Enriched descriptionDescription Enriched

Cadila Pharmaceuticals is an Indian multinational pharmaceuticals company that provides high quality, affordable, and innovative solutions in medicine and treatment.

Metadata descriptionDescription Metadata Raw

An Indian multinational pharmaceuticals company that provides high quality, affordable and innovative solutions in medicine and treatment.

LinkedIn followers

602.7K

Latest linkedin followers value available from the source dataset.

Owler followers

408

Latest owler followers value available from the source dataset.

Technologies detected

127

Latest technologies detected value available from the source dataset.

Ownership and corporate structure
Ownership status, parent company, acquisition status, and public/B2B flags.

Operating status

Active

Independent Company

Company type

Privately Held

type

Ownership status

Private

Ownership Status

Public company

No

Is Public

Aliases and domain variants
Company name aliases, website aliases, and canonical domain signals.

Company alias

cadila pharmaceuticals limited

Company Name Alias

Company alias

cadila pharmaceuticals

Company Name Alias

Company alias

cadila pharmaceuticals ltd.

Company Name Alias

Website alias

https://www.cadilapharma.com

Website Alias

Website alias

https://www.cadilapharma.com/

Website Alias

Canonical website

https://www.cadilapharma.com

website

Website domain

cadilapharma.com

Website Domain

Unique website

Yes

Unique Website

Unique domain

Yes

Unique Domain

Expired domain

No

Expired Domain

LinkedIn shorthand

cadila-pharmaceuticals

Canonical LinkedIn Shorthand Name

Source ID

54739

Source ID

UUID

248QF0EH8Q362T1EMPRJPR3CW8

uuid

Industry classification codes
SIC, NAICS, industry, and keyword classification signals.

SIC code

28

SIC Codes

SIC code

283

SIC Codes

NAICS code

32

NAICS Codes

NAICS code

325

NAICS Codes

Industry

Pharmaceutical Manufacturing

industry

Categories and keywords

['pharmaceuticals', 'finished formulations', 'pre-clinical/clinical trials', 'agro products', 'discovery research services', 'pharma machinery', 'contract manufacturing', 'generic drugs', 'bulk drugs / apis', 'innovative solutions', 'treatment', 'indian', 'medicine', 'health', 'biotech', 'drug-development', 'pharma', 'biotechnology', 'health care', 'manufacturing', 'pharmaceutical']

Categories And Keywords

Social follower counts
Follower counts available across LinkedIn, Twitter, and Owler.

LinkedIn followers

602.7K

Followers Count LinkedIn

Owler followers

408

Followers Count Owler

Company locations
Known company locations and office addresses.

Primary location

Sarkhej-Dholka Road; Bhat; Ahmedabad, Gujarat 382210, IN

Office location

Survey No. 342, Nani Kadi; Taluka Kadi; Dist. Mehsana, Gujarat, IN

Office location

Survey No. 1389, Trasad Road; Dholka; Ahmedabad, Gujarat 387 810, IN

Office location

294, GIDC Estate; Ankleshwar, Gujarat, IN

Office location

Dholka Rd, Rajoda; Bavla, Gujarat, India

Office location

Sarkhej-Dholka Road; Ahmedabad, 382 210, India

Office location

Ahmedabad, Gujarat, India

Office location

Bhat Sarkhej-dholka Rd; Sarkhej, Gujarat 382210, India

Social profiles
Official and source-linked social profiles.

Website

https://www.cadilapharma.com

LinkedIn

https://in.linkedin.com/company/cadila-pharmaceuticals

Crunchbase

https://www.crunchbase.com/organization/cadila-pharmaceuticals

Facebook

https://www.facebook.com/officialcadilapharma

Twitter / X

https://www.twitter.com/cadila_pharma

Instagram

https://www.instagram.com/cadilapharmaceuticals

YouTube

https://www.youtube.com/channel/ucte71y-ursyxkcqdo-elnwq

Company contact points
Public company-level contact points available in the source dataset.

Email

website@cadilapharma.co.in

Phone

(1926-2012

Phone

91-2718-225001

Phone

+91-2718-225001

Financial intelligence

Cadila Pharmaceuticals Limited revenue, funding, IPO, and acquisition history

Financial signals are grouped as an analyst-style view: revenue sources, income statement rows, funding rounds, acquisition activity, IPO fields, stock listing context, and ownership structure.

Annual revenue
$2.5B
Reported annual revenue from the source dataset when available.
Acquisitions captured
1
Number of acquisition records captured across the available source columns.
Revenue signals
Annual, quarterly, and range-based revenue signals available in the source dataset.

Source 5

$2.5B

Annual revenue

Ownership and corporate structure
Ownership status, parent company, acquisition status, and public/B2B flags.

Operating status

Active

Independent Company

Company type

Privately Held

type

Ownership status

Private

Ownership Status

Public company

No

Is Public

Acquisitions and corporate activity
Acquisitions and corporate activity captured in the source dataset.

BioChromix AB

Acquisition

2014-10-01 | Acquisition List Source 2

Audience analytics

Web visibility, demand, and topics

Use these signals to understand discoverability, demand quality, search interest, and audience fit.

Monthly visits

20.4K

Latest monthly visits value available from the source dataset.

Global web rank

#794,135

Lower rank values indicate stronger web visibility in the source dataset.

Bounce rate

38.0%

Latest bounce rate value available from the source dataset.

Pages per visit

6.73

Latest pages per visit value available from the source dataset.

Average visit duration

2m 25s

Latest average visit duration value available from the source dataset.

Estimated monthly page views

137.5K

Derived estimate calculated as monthly visits multiplied by pages per visit.

Website visits
Website visits trend from the latest source snapshots.
LinkedIn followers
LinkedIn followers trend from the latest source snapshots.
Website visits by country
India70.84
Nigeria14.79
United States12.41
Pakistan1.9
Top search topics
Search topics and queries associated with the company.

cadila

Associated search topic

cadila pharmaceuticals

Associated search topic

cadila pharmaceuticals limited

Associated search topic

aciloc 150

Associated search topic

cadila pharmaceuticals ltd

Associated search topic

Social profiles
Official and source-linked social profiles.

Website

https://www.cadilapharma.com

LinkedIn

https://in.linkedin.com/company/cadila-pharmaceuticals

Crunchbase

https://www.crunchbase.com/organization/cadila-pharmaceuticals

Facebook

https://www.facebook.com/officialcadilapharma

Twitter / X

https://www.twitter.com/cadila_pharma

Instagram

https://www.instagram.com/cadilapharmaceuticals

YouTube

https://www.youtube.com/channel/ucte71y-ursyxkcqdo-elnwq

Company contact points
Public company-level contact points available in the source dataset.

Email

website@cadilapharma.co.in

Phone

(1926-2012

Phone

91-2718-225001

Phone

+91-2718-225001

Social follower counts
Follower counts available across LinkedIn, Twitter, and Owler.

LinkedIn followers

602.7K

Followers Count LinkedIn

Owler followers

408

Followers Count Owler

Workforce intelligence

Employees, hiring, attrition, and compensation

This section groups org scale, hiring motion, employee movement, department mix, and salary benchmarks so teams can qualify operating momentum and budget signals.

Employees

9.3K

Latest employees value available from the source dataset.

Inferred employees

3.6K

Latest inferred employees value available from the source dataset.

Open roles

9

Latest open roles value available from the source dataset.

Departures

0

Latest departures value available from the source dataset.

Employee attrition rate

0.0%

Latest employee attrition rate value available from the source dataset.

Hiring intensity

1.0 roles / 1K employees

Derived signal showing open roles normalized by employee count.

Employee headcount
Employee headcount trend from the latest source snapshots.
Inferred employees
Inferred employees trend from the latest source snapshots.
Open job postings
Open job postings trend from the latest source snapshots.
Employee attrition rate
Employee attrition rate trend from the latest source snapshots.
Employee count by department
Sales732
Operations704
General Management618
Other Department336
Research238
Technical214
Medical188
Employee count by seniority
Manager1.4K
Specialist1.3K
Other Management423
Senior285
Clevel113
Intern85
Vp72
Employee count by region
Southern Asia3.5K
Sub Saharan Africa58
Northern Europe14
Unknown13
Northern America11
Western Asia10
Eastern Europe8
Top employee countries
India3.5K
Ethiopia21
Kenya16
United Kingdom13
Nepal13
United States7
Nigeria7
Active job openings
Selected open roles that reveal current hiring demand.

Deputy General Manager:- SAP PPDS

Open role

4404165568

Executive:- Import Documentation

Open role

4405100617

Senior Manager

Open role

4397929516

Head MENA

Open role

4405229027

Deputy General Manager:- SAP FICO

Open role

4404158951

DGM:- SCM Centre of Excellence

Open role

4401919983

General Manager:- HR Digitalization

Open role

4404144707

Assistant Manager:- SAP (Sales & Distribution)

Open role

4404158938

Showing 8 of 9 available records.

Where employees came from
Common previous employers visible in employee profile movement.

Zydus Group

309 employee movements

Internal profile link

Intas Pharmaceuticals

281 employee movements

Internal profile link

Torrent Pharmaceuticals Ltd

207 employee movements

Internal profile link

Cipla

133 employee movements

Internal profile link

Alkem Laboratories Ltd.

127 employee movements

Internal profile link

SUN PHARMA

122 employee movements

Internal profile link

Ipca Laboratories Limited

114 employee movements

Internal profile link

Alembic Pharmaceuticals Limited

108 employee movements

Internal profile link

Showing 8 of 10 available records.

Where employees go next
Common next employers visible in employee profile movement.

Intas Pharmaceuticals

446 employee movements

Internal profile link

Zydus Group

328 employee movements

Internal profile link

Torrent Pharmaceuticals Ltd

239 employee movements

Internal profile link

SUN PHARMA

206 employee movements

Internal profile link

Cipla

167 employee movements

Internal profile link

Alembic Pharmaceuticals Limited

148 employee movements

Internal profile link

Amneal Pharmaceuticals

129 employee movements

Internal profile link

Alkem Laboratories Ltd.

126 employee movements

Internal profile link

Showing 8 of 10 available records.

Base pay benchmarks
Selected base salary benchmarks from the source dataset.

Management Trainee

INR $1M

Annual | Updated 2024-08-25

Operational Excellence Manager

INR $971.9K

Annual | Updated 2023-12-29

Sales

INR $377K

Monthly | Updated 2024-02-02

Deputy Manager

INR $1M

Annual | Updated 2024-04-19

Assistant Manager

GBP $980.6K

Annual | Updated 2024-08-22

Assistant Product Manager

INR $1M

Annual | Updated 2022-09-07

Senior Manager

INR $1.9M

Annual | Updated 2023-02-22

Field Officer

INR $235.8K

Monthly | Updated 2024-01-23

Showing 8 of 10 available records.

Additional pay benchmarks
Selected bonus and additional compensation benchmarks.

Assistant Manager

Cash Bonus $67.3K

Annual | Updated 2024-08-22

Sales

Cash Bonus $4.19; Stock Bonus $4.23; Profit Sharing $4.24

Monthly | Updated 2024-02-02

Senior Manager

Cash Bonus $269.3K

Annual | Updated 2023-02-22

Assistant Product Manager

Commission Sharing $281.3K

Annual | Updated 2022-09-07

Field Officer

Cash Bonus $31.1K

Monthly | Updated 2024-01-23

Total compensation benchmarks
Selected total compensation benchmarks from the source dataset.

Management Trainee

INR $1M

Annual | Updated 2024-08-25

Assistant Manager

GBP $1M

Annual | Updated 2024-08-22

Deputy Manager

INR $1M

Annual | Updated 2024-04-19

Product Manager

INR $777.5K

Annual | Updated 2024-03-11

Process Engineer

INR $1M

Annual | Updated 2024-02-29

Sales

INR $936.5K

Monthly | Updated 2024-02-02

Field Officer

INR $251.3K

Monthly | Updated 2024-01-23

Operational Excellence Manager

INR $971.9K

Annual | Updated 2023-12-29

Showing 8 of 10 available records.

Product and reputation

Product readiness, customer proof, and employee sentiment

Product availability, public reviews, and employee sentiment help visitors understand whether the company is mature, documented, reviewable, and operationally healthy.

Employee reviews

396

Latest employee reviews value available from the source dataset.

Employee rating

4.0

Latest review score available from the source dataset.

Employee review distribution
Score 5104
Score 390
Score 478
Score 167
Score 229
Employee review score breakdown
Compensation Benefits4.1
Career Opportunities4
Diversity Inclusion4
Senior Management3.9
Culture Values3.8
Work Life Balance3.8
Ceo Approval82.0%
Product availability Q&A
Buyer-facing product availability signals in question-and-answer format.

Is pricing information available?

No. The source snapshot does not list pricing information for this company.

Source availability signal

Is a free trial listed?

No. The source snapshot does not list a free trial for this company.

Source availability signal

Can buyers request a demo?

No. The source snapshot does not list a demo motion for this company.

Source availability signal

Is the product downloadable?

No. The source snapshot does not list downloadable software for this company.

Source availability signal

Are mobile apps listed?

No. The source snapshot does not list mobile apps for this company.

Source availability signal

Is public documentation listed?

No. The source snapshot does not list public documentation for this company.

Source availability signal

Are online reviews listed?

No. The source snapshot does not list online reviews for this company.

Source availability signal

Company graph

Technology, leadership, competitors, funding, and corporate activity

These data points help sales, partnerships, analysts, and researchers understand how the company operates, who surrounds it, and where it may be moving next.

Verified technologies
Detected tools and systems verified in the source dataset.

Oracle 9I

Verified technology

Last verified 2026-05-04 | First seen 2025-08-17

Empower 3 Software

Verified technology

Last verified 2026-05-04 | First seen 2026-03-29

Msci

Verified technology

Last verified 2026-05-04 | First seen 2026-04-28

Scada

Verified technology

Last verified 2026-05-04 | First seen 2025-08-17

Ukg

Verified technology

Last verified 2026-05-04 | First seen 2025-12-15

Oracle

Verified technology

Last verified 2026-05-04 | First seen 2025-08-17

Linkedin

Verified technology

Last verified 2026-05-04 | First seen 2024-05-20

Perkinelmer

Verified technology

Last verified 2026-05-04 | First seen 2026-04-12

Showing 8 of 24 available records.

Market alternatives and competitors
Comparable companies surfaced by the source dataset.

Ucb

Comparable company

Market alternative

Cipla

Comparable company

Market alternative

Syngene International

Comparable company

Market alternative

Biological E

Comparable company

Market alternative

Nexgen

Similarity 6,219.0

Market alternative

Titan Pharma

Similarity 85,799.0

Market alternative

Laborate

Similarity 7,901.0

Market alternative

Aurobindo Pharma

Similarity 10,627.0

Market alternative

Showing 8 of 12 available records.

Leadership and senior operators
Senior employees and operators visible in the source dataset.

CA. Tejas P.

Head - Project Finance

Bhargav Asodariya

Executive

Manoj Solanki

Head Librarian

Rajendra Wakhale

Head (Banking, Treasury, Insurance, Projects)

Malav Joshi

Assistant Vice President

vivek verma

Executive

Pujan Pandya

Executive

Vishal Shah

Head Of Quality Control

Showing 8 of 12 available records.

Recent executive arrivals
Recent leadership and senior employee arrival signals.

Avinash Kumar Talwar

President Purchase

Apr 2026

Malav Joshi

Assistant Vice President

Feb 2026

Naresh Patel

Executive

Mar 2026

Olivia Chakraborty

Executive

Apr 2026

Vinit Dixit

Executive

Dec 2025

Yogesh Talpada

Executive

Jan 2026

Vivek Yadav

Executive

Feb 2026

Kinjal Choudhary

Chief People Transformation Officer

Jan 2026

Recent executive departures
Recent leadership and senior employee departure signals.

Kamalesh Kalidasan

President - Branded SBU’s

Dec 2025

Dhruv Pratap Singh

Country Head HR - Manufacturing

Feb 2026

César A. M.

Vice President Latam

Jan 2026

Nagesh Mune

Cluster Head

Jan 2026

Nagesh Mune

Joint President-Cluster Head

Jan 2026

Amit Kulshrestha

Assistant Vice President Sales and Marketing (Respiratory Business)

Dec 2025

Aditya khadke

Executive

Jan 2026

Company locations
Known company locations and office addresses.

Primary location

Sarkhej-Dholka Road; Bhat; Ahmedabad, Gujarat 382210, IN

Office location

Survey No. 342, Nani Kadi; Taluka Kadi; Dist. Mehsana, Gujarat, IN

Office location

Survey No. 1389, Trasad Road; Dholka; Ahmedabad, Gujarat 387 810, IN

Office location

294, GIDC Estate; Ankleshwar, Gujarat, IN

Office location

Dholka Rd, Rajoda; Bavla, Gujarat, India

Office location

Sarkhej-Dholka Road; Ahmedabad, 382 210, India

Office location

Ahmedabad, Gujarat, India

Office location

Bhat Sarkhej-dholka Rd; Sarkhej, Gujarat 382210, India

Recent company updates
Recent company update signals from the source dataset.

CPL Pharma Pvt. Ltd.: Your Trusted CDMO-CMO Partner CPL Pharma Pvt. Ltd. delivers end-to-end CDMO-CMO solutio…

51 reactions

2026-04-23 | CPL Pharma Pvt. Ltd.: Your Trusted CDMO-CMO Partner CPL Pharma Pvt. Ltd. delivers end-to-end CDMO-CMO solutions and accelerates the journey from molecule to market—enabling faster, safer, and smarter global access to li…

Our Power. Our Planet. Collective Action for a Sustainable Future Every choice matters. Every action counts.…

56 reactions

2026-04-22 | Our Power. Our Planet. Collective Action for a Sustainable Future Every choice matters. Every action counts. Together, communities can drive real change—towards cleaner energy, stronger ecosystems, and a healthier plane…

High-quality APIs are engineered to meet stringent global benchmarks, driven by precision, consistency, and r…

67 reactions

2026-04-20 | High-quality APIs are engineered to meet stringent global benchmarks, driven by precision, consistency, and regulatory rigor   Meet our team at CPHI Japan 2026 | 21–23 April | Booth 2C-33. #CadilaPharmaceuticals #Cadil…

Prioritizing Liver Health for a Healthier Tomorrow: Guided by the focus of the World Health Organization on p…

42 reactions

2026-04-19 | Prioritizing Liver Health for a Healthier Tomorrow: Guided by the focus of the World Health Organization on prevention, early screening, and equitable access to care, the importance of timely diagnosis and informed life…

Driving Growth. Celebrating Prosperity. May this Akshaya Tritiya bring in abundance, good fortune & new begin…

150 reactions

2026-04-19 | Driving Growth. Celebrating Prosperity. May this Akshaya Tritiya bring in abundance, good fortune & new beginnings to you and your family. #CadilaPharmaceuticals #CadilaPharma #AkshayaTritiya #FestiveWishes #Prosperity…

APIs that deliver high-quality solutions—driven by Cadila Pharma’s commitment to excellence. Meet our team at…

65 reactions

2026-04-18 | APIs that deliver high-quality solutions—driven by Cadila Pharma’s commitment to excellence. Meet our team at CPHI Japan 2026 | 21–23 April | Booth 2C-33. #CadilaPharmaceuticals #CadilaPharma #CPHIJapan2026 #PharmaExhi…

Industry classification codes
SIC, NAICS, industry, and keyword classification signals.

SIC code

28

SIC Codes

SIC code

283

SIC Codes

NAICS code

32

NAICS Codes

NAICS code

325

NAICS Codes

Industry

Pharmaceutical Manufacturing

industry

Categories and keywords

['pharmaceuticals', 'finished formulations', 'pre-clinical/clinical trials', 'agro products', 'discovery research services', 'pharma machinery', 'contract manufacturing', 'generic drugs', 'bulk drugs / apis', 'innovative solutions', 'treatment', 'indian', 'medicine', 'health', 'biotech', 'drug-development', 'pharma', 'biotechnology', 'health care', 'manufacturing', 'pharmaceutical']

Categories And Keywords

Cadila Pharmaceuticals Limited FAQs

Company profile

Want verified contact data for Cadila Pharmaceuticals Limited?

Datakart.ai gives you verified email addresses, direct dials, and buying intent signals for key decision-makers at Cadila Pharmaceuticals Limited and 1,700+ other companies.